[Current strategies in the treatment of atrial fibrillation].
Drewitz
Imke
I
Universitäres Herzzentrum GmbH, Klinik für Kardiologie, Angiologie, Hamburg, Germany. idrewitz@uke.uni-hamburg.de
Rostock
Thomas
T
Hoffmann
Boris
B
Steven
Daniel
D
Servatius
Helge
H
Meinertz
Thomas
T
Willems
Stephan
S
D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage / Q000009:adverse effects; D000925:Anticoagulants / Q000009:adverse effects; D001281:Atrial Fibrillation / Q000175:diagnosis / Q000628:therapy*; D002304:Cardiac Pacing, Artificial; D017115:Catheter Ablation; D004554:Electric Countershock; D015716:Electrocardiography, Ambulatory; D005424:Flecainide / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D011667:Pulmonary Veins / Q000601:surgery; D012008:Recurrence; D019233:Retreatment; D013614:Tachycardia, Paroxysmal / Q000628:therapy*
D000889:Anti-Arrhythmia Agents; D000925:Anticoagulants; D005424:Flecainide